X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 28/Aug 00:08

Astellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in Women with Breast Cancer Receiving Adjuvant Endocrine Therapy

TOKYO, Aug. 27, 2024. Astellas Pharma Inc. (today announced dosing of the first patient in the HIGHLIGHT 1 Phase 3 pivotal study for fezolinetant, an investigational oral, nonhormonal compound being studied for the treatment of moderate to severe...

Articles similaires

Sorry! Image not available at this time

Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome

drugs.com - 02/Sep 04:09

PASADENA, Calif.–(BUSINESS WIRE)–Sep. 2, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced results from the Phase 3 PALISADE...

Sorry! Image not available at this time

Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals

zacks.com - 05/Sep 14:56

BIIB's pivotal mid to late-stage study evaluating a higher dosing regimen for Spinraza to treat SMA in infants meets the primary and secondary goals.

Sorry! Image not available at this time

Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals

zacks.com - 05/Sep 14:56

BIIB's pivotal mid to late-stage study evaluating a higher dosing regimen for Spinraza to treat SMA in infants meets the primary and secondary goals.

Sorry! Image not available at this time

Neurocrine Biosciences Provides Update on ERUDITE Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with Schizophrenia

drugs.com - 13/Sep 06:09

SAN DIEGO, Sept. 12, 2024. Neurocrine Biosciences, Inc. today announced that its ERUDITE Phase 2 clinical study of investigational compound...

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances

healthtechzone.com - 03/Sep 22:45

Sorry! Image not available at this time

VEOZAH (fezolinetant) tablet, film coated [Astellas Pharma US, Inc.]

nlm.nih.gov - 09/Sep 04:00

Updated Date: Mon, 09 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

VEOZAH (fezolinetant) tablet, film coated [Astellas Pharma US, Inc.]

nlm.nih.gov - 09/Sep 04:00

Updated Date: Mon, 09 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

Relay Stock Soars on Upbeat Data From Breast Cancer Study

zacks.com - 10/Sep 14:55

RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for...

Les derniers communiqués